OTCMKTS:LKYSF Numinus Wellness (LKYSF) Stock Price, News & Analysis → The A.I. story nobody is telling you (Read ASAP) (From TradeSmith) (Ad) Free LKYSF Stock Alerts $0.05 0.00 (0.00%) (As of 05/2/2024 ET) Add Compare Share Share Today's Range$0.05▼$0.0550-Day Range$0.05▼$0.0952-Week Range$0.32▼$1.93Volume55,364 shsAverage Volume522,497 shsMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartHeadlinesStock AnalysisChartHeadlines Get Numinus Wellness alerts: Email Address Ad Paradigm PressBiden out June 13; Kamala won’t replace him?On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in the 2024 presidential election.See who it is HERE. About Numinus Wellness Stock (OTCMKTS:LKYSF)Numinus Wellness, Inc. operates as a Canadian health care company empowering healing and wellness through the development and delivery of safe, evidence-based psychedelic-assisted therapies for mental illness, substance abuse and trauma. The Numinus model comprises psychedelic production, clinical research and clinical care, with a Health Canada-licenced research facility, seasoned medical team and growing network of clinics. The company's licence allows for a range of research activities and import, export and distribution of psychedelic substances including DMT, ketamine, LSD, MDMA, mescaline, psilocybin, psilocin. It operates through the following segments: Salvation Botanicals, Numinus Health and Salvation Bioscience. The Salvation Botanicals segment engages in psychedelic substance research, developing intellectual property while offering analytics services for revenue generation. Its laboratory provides services including cultivation, analytical testing, product research and development, and ancillary services in the area of psychedelics. The Numinus Health segment operates the wellness centre where professional therapists and health professionals use supportive therapies andRead More LKYSF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart LKYSF Stock News HeadlinesJanuary 20, 2024 | benzinga.comNuminus Wellness Stock (OTC:NUMIF), Analyst Ratings, Price Targets, PredictionsJanuary 19, 2024 | benzinga.comNuminus Wellness Stock (OTC:NUMIF) Dividends: History, Yield and DatesMay 2, 2024 | Altimetry (Ad)Urgent Nvidia WarningCould Steve Job's 'Final Prophecy' Make You Rich? Just before he died, Steve Jobs issued a "Final Prophecy" that's now coming true... and making some people rich. In one recent 90-day stretch, 50 companies related to Jobs' "Final Prophecy" soared by 100% or more. What was Steve Jobs' last big prediction, and how can you get in on it? Professor Joel Litman explains everything... including the surprising group of stocks moving higher, and his No. 1 favorite stock in this space.January 8, 2024 | theglobeandmail.comClosing Bell: Numinus Wellness Inc up on Thursday (NUMI)January 8, 2024 | theglobeandmail.comClosing Bell: Numinus Wellness Inc up on Friday (NUMI)January 6, 2024 | theglobeandmail.comClosing Bell: Numinus Wellness Inc up on Tuesday (NUMI)December 17, 2023 | investing.comNuminus Wellness Inc (NUMI) Earnings Dates & ReportsNovember 6, 2023 | theglobeandmail.comClosing Bell: Numinus Wellness Inc up on Wednesday (NUMI)May 2, 2024 | Altimetry (Ad)Urgent Nvidia WarningCould Steve Job's 'Final Prophecy' Make You Rich? Just before he died, Steve Jobs issued a "Final Prophecy" that's now coming true... and making some people rich. In one recent 90-day stretch, 50 companies related to Jobs' "Final Prophecy" soared by 100% or more. What was Steve Jobs' last big prediction, and how can you get in on it? Professor Joel Litman explains everything... including the surprising group of stocks moving higher, and his No. 1 favorite stock in this space.November 5, 2023 | morningstar.comNuminus Wellness Inc Ordinary Shares NUMIFSeptember 26, 2023 | proactiveinvestors.comNuminus Wellness announces at-the-market equity offering programSeptember 19, 2023 | proactiveinvestors.comNuminus Wellness hails study results as milestone for psychedelics industrySeptember 19, 2023 | proactiveinvestors.comNuminus Wellness hails MAPS study results as significant milestone for the psychedelics industrySeptember 19, 2023 | proactiveinvestors.comNuminus Wellness takes strategic measures to accelerate toward...June 22, 2023 | proactiveinvestors.comNuminus Wellness announces partnership with HealingMapsJune 5, 2023 | proactiveinvestors.comNuminus Wellness designated as a top research site for MindMed studyMay 30, 2023 | proactiveinvestors.comNuminus Wellness announces largest-of-its-kind study of psilocybin therapy to treat depressionMay 25, 2023 | proactiveinvestors.comNuminus Wellness positioned to lead in MDMA-assisted therapy as FDA approval nearsApril 11, 2023 | proactiveinvestors.comNuminus Wellness launches new clinic licensing platform to accelerate expansionMarch 27, 2023 | proactiveinvestors.comNuminus launches practitioner Certification Pathway -a complete psychedelic-assisted therapy training programMarch 7, 2023 | prnewswire.comNuminus Wellness Inc. Executives to Present on Panel at Upcoming South by Southwest ConferenceFebruary 18, 2023 | theglobeandmail.comClosing Bell: Numinus Wellness Inc flat on Thursday (NUMI)February 17, 2023 | proactiveinvestors.comNuminus Wellness expands research capabilities with new Phoenix siteJanuary 17, 2023 | finance.yahoo.comNuminus Wellness Inc. (NUMIF)January 17, 2023 | proactiveinvestors.comNuminus Wellness reports surge in 1Q revenue as Novamind acquisition beds inJanuary 17, 2023 | proactiveinvestors.comNuminus Wellness reports surge in 1Q revenue as Novamind acquisition beds downDecember 16, 2022 | proactiveinvestors.comProactive research analyst on Numinus Wellness' annual resultsSee More Headlines Receive LKYSF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Numinus Wellness and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medical & Nursing Services Sub-IndustryN/A Current SymbolOTCMKTS:LKYSF CUSIPN/A CIKN/A Webwww.numinus.ca Phone(833) 686-4687FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesPayton NyquvestChairman, President & Chief Executive OfficerMichael TanChief Operating Officer & DirectorJohn FongChief Financial Officer & SecretaryEvan WoodChief Medical OfficerDevon ChristieMedical DirectorKey CompetitorsVigil Health SolutionsOTCMKTS:VIGLF180 Life SciencesNASDAQ:ATNFW1933 IndustriesOTCMKTS:TGIFF3SBioOTCMKTS:TRSBF4Cable TV InternationalOTCMKTS:CATVView All Competitors LKYSF Stock Analysis - Frequently Asked Questions How have LKYSF shares performed in 2024? Numinus Wellness' stock was trading at $0.0816 at the beginning of the year. Since then, LKYSF stock has decreased by 36.3% and is now trading at $0.0520. View the best growth stocks for 2024 here. How do I buy shares of Numinus Wellness? Shares of LKYSF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:LKYSF) was last updated on 5/2/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressUrgent Nvidia WarningAltimetryThe A.I. story nobody is telling you (Read ASAP)TradeSmithYour bank is lying to you.MyBankTrackerThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingTrump just won 2024Porter & CompanyHe Is Giving Away BitcoinCrypto Swap Profits Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Numinus Wellness Inc Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.